Analysis of Preclinical and Clinical Samples After Treatment With a CD37 Targeting Antibody Drug Conjugate (AGS67E) Support a High Level of CD37 Expression in NHL
Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_20
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley